CA2211629A1 - Vial connector assembly for a medicament container - Google Patents
Vial connector assembly for a medicament containerInfo
- Publication number
- CA2211629A1 CA2211629A1 CA 2211629 CA2211629A CA2211629A1 CA 2211629 A1 CA2211629 A1 CA 2211629A1 CA 2211629 CA2211629 CA 2211629 CA 2211629 A CA2211629 A CA 2211629A CA 2211629 A1 CA2211629 A1 CA 2211629A1
- Authority
- CA
- Canada
- Prior art keywords
- collar
- vial
- rim
- connector assembly
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2031—Separating means having openings brought into alignment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2051—Connecting means having tap means, e.g. tap means activated by sliding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2055—Connecting means having gripping means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2068—Venting means
- A61J1/2072—Venting means for internal venting
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S215/00—Bottles and jars
- Y10S215/03—Medical
Abstract
A connector assembly provided for efficient flow of liquid into and/or out of a vial, such as a vial containing a lyophilized drug The connector assembly features a collar mountable to the rim of the vial in a locked position and thereafter removable by an end-user when disposal of the device is desired. A protective cap mountable over the collar includes a annulus-type ring at its proximal end which mounts over locking structure associated with the collar. The ring is secured to the protective cap via one or more user-severable connections. As the cap is urged proximally, the ring places the collar in the locked position with the vial rim, exerting an inwardly-directed force onto the locking structure the collar to the vial rim. The cap can be separated from the ring at its user-severable connections, and the device used in its ordinary matter. When disposal is desired, the ring may be urged proximally out of engagement with the locking structure of the collar The collar may thereafter be removed from the vial to facilitate separate disposal of those components.
Description
' CA 02211629 1997-07-28 PATENT APPLICATION
OF
~UBERT JANSEN, JEAN CLAUDE TEIBAULT, -- AND BERNARD SAMS
FOR
0 AN Il~'fP~OVED VL~L CONNEC~OR ASSEMBLY FOR
A MEDIC~MENT CONTAINE~
E~ACKGROUND OF THE ~N~ENTION
I. Field of the Invention. The subject invention relates to a connector assemblyfor a vial, and more particularly, to a connector assembly for a vial which can be safely removed from the vial after use to facilitate the disposal of the various components.
OF
~UBERT JANSEN, JEAN CLAUDE TEIBAULT, -- AND BERNARD SAMS
FOR
0 AN Il~'fP~OVED VL~L CONNEC~OR ASSEMBLY FOR
A MEDIC~MENT CONTAINE~
E~ACKGROUND OF THE ~N~ENTION
I. Field of the Invention. The subject invention relates to a connector assemblyfor a vial, and more particularly, to a connector assembly for a vial which can be safely removed from the vial after use to facilitate the disposal of the various components.
2. Description of the Prior Art. Many drugs are presented in dry form to achieve a longer shelf life. These drugs are reconstituted by a suitable solvent into liquid form for delivery to a patient. One type of dry drug is a Iyophilized drug.
In the art, there are a number of ways to store dry drugs such as lyophilized drugs in a form conducive to reconstitution and delivery. Some of these products are exemplified, for example, by the MONOVIAL~-brand prefillable drug delivery devices m~nllf~ctllred and sold by Becton Dickinson Pharmaceutical Systems of Le Pont de Claix, France. Such systems are further exemplified, for instance, in U.S. Patent No. 5,358,501, issued to Gabriel Meyer on October 25, 1994. While there are variations of such systems, in general, they feature vials made of glass or suitable plastic materials, in which a selected dose of a Iyophilized drug may be stored. The vial is generally sealed to prevent deterioration or cont~min~tion of the drug. The dry drug may be reconstituted with a liquid solvent shortly prior to use, and the now reconstituted drug solution may be administered to a patient.
Various components are employed with the prefillable drug-delivery systems described above. For instance, the vials are typically provided with a vial connector assembly to enable attachment of the vial to a source of solvent to reconstitute the dry . CA 02211629 1997-07-28 _.
drug The same vial connector is also normally used to attach the vial to an intravenous fitting to deliver the reconstituted drug to a patient. Vial connectors such as used with the prefillable drug delivery systems described above typically include one or more components necessary for the function of the system For instance, one or more rubber s stopper or membrane components are provided to seal the vial until such time as access to the drug, in its dry or liquid form, is desired. A fluid transfer device, such as a needle or spike, is also provided, both to provide means for introducing solvent into the vial and for delivering the reconstituted drug out of the vial. Generally, a collar component is provided adjacent the rim of the vial to secure the various parts, such as the fluid transfer 0 device and the sealing components, associated with the vial connector.
Depending on the configuration of the prefillable drug-delivery system, the system might be activated by moving the collar relative to the vial rim, wherein the fluid transfer device and sealing components are fixed relative to the collar, or by moving the fluid transfer device and sealing components relative to the vial, wherein the collar is fixed 15 relative to the vial rim. movable manner relative to the collar. Accordingly, depending on the configuration, the system can be activated either by causing motion between the collar and the rim, or by causing motion between the fluid transfer device and/or sealing components relative to the collar.
One aspect of the aforementioned systems is that subsequent to use, the various 20 components, such as the fluid transfer device, sealing components, and the collar itself remain fixed to the vial. Here, once the drug has been delivered to the patient, the entire system is disposed of whole in a sterile manner. Owing to the di~el ellt materials used for the various components, benefits may be realized in configuring a system wherein the components can be separated from one another in a safe manner to facilitate disposal. For 25 instance, certain governmental regulations or accepted practices may encourage disposing of the vial, which contained the drug in its dry and reconstituted forms, separately from the transfer assembly.
- SUMMA~Y OF THE ~NVENTION
The subject invention is directed to a connector assembly for use with a vial. The vial includes a bottom wall and an upstanding side wall. A shoulder extends inwardly from the top end of the side wall and a tubular neck extends upwardly from the shoulder to an open top. An annular rim may extend around portions of the neck that define the .
~ P- ,632 , - open top. Portions of the vial between the tubular neck and the bottom wall define an enclosure in which a Iyophilized drug or a drug solution may be stored.
A novel aspect of the connector assembly in accordance with the present invention is that it is mountable to the neck of the vial in a manner such that it may be safely 5 removed by a practitioner, such that the connector assembly may be disposed of separately from the vial. The connector assembly can be employed with various fluid transfer devices, such as a needle, a spike or a luer. as means for introducing solvent into the vial and for delivering a reconstituted drug out of the vial. Various stoppers and membrane components may be provided in conjunction with the connector assembly to seal the vial lo until such time as access to the drug, in its dry or liquid form, is desired.The connector assembly includes a collar mountable to the rim of the vial neck.
The collar includes a proximal end, a distal end, and a sidewall therebetween. A plurality of deflectable latches are provided adjacent the proximal end of the collar. The plurality of deflectable latches each include locking means deflectable about a side portion of the rim 15 for secure engagement with the underside of the rim In one configuration, the locking means can be formed as a proximally facing, inwardly canted locking surface provided adjacent the proximal end of each of the deflectable latches.
The connector assembly includes a protective cap mountable about the sidewall portion of the collar which cooperates with the collar to secure the connector assembly to 20 the vial rim. The protective cap features an open plo~h-,al end, a closed distal end, and a shield wall formed therebetween. A ring is provided adjacent the open proximal end of the protective cap. The ring features an annulus-section with an interior surface cooperable with structure associated with the deflectable latches and is connected to the proximal end of the protective cap by one or more user-severable connections. In one 25 embodiment, the user-severable connections are formed as one or more frangible sections formed between the proximal end of the cap and a distal end end of the ring. The ring may include a rib element formed at a proximal end thereof. The rib element may cooperate with structure provided on the deflectable latches to prevent further distal movement of the ring after the collar is urged into a locked position with the vial rim. The 30 interior surface of the annular section may define a diameter equal to, or slightly less than, a diameter defined by a diametrically opposed pair of deflectable latches, such that the annulus section will apply an inwardly-directed holding force onto the deflectable latches.
The inwardly directed force will retain the collar in a locked position respective of the vial rlm.
, The device may be supplied to a pharmaceutical manu~acturer in a manner to enable processing and filling of the vial with a desired drug. After the drug is filled into the vial, the collar can be lockingly secured to the vial nm for shipment to an end user.
The collar, together with the fluid transfer device and the various sealing stoppers and/or membranes associated with the connector assembly, are positioned in a manner to seal the open top of the vial. The protective cap is then mounted about the sidewall portion of the collar If provided, sterility ribs provided on an interior portion of the cap cooperate with the sidewall of the collar to provide added sealing security for the drug retained within the vial as well as for the various components associated with the connector assembly.
o Continued proximal motion of the cap relative to the collar will cause the annulus section to engage the deflectable latches, such that cap and collar are both moved proximally relative to the rim. The action of the protective cap against the collar and, in particular, engagement forces exerted between the annulus section of the ring and the deflectable latches of the collar, causes the deflectable latches, and particularly the locking 15 means associated therewith, to move into secure engagement with an underside portion of the rim. The annulus section proceeds proximally relative to the collar, such that the interior surface of the annulus-section is disposed in covering relationship with the deflectable latches of the collar. The rib element provided at the proximal end of the ring retains the ring in fixed position relative to the deflectable latches in a manner such that the 20 ring cannot be further removed in a distal direction. Accordingly, inwardly directed forces are exerted by the annulus-section onto the deflectable latches, to hold the collar in locked position relative to the rim. The device may thus be shipped to an end-user.
The device may be activated by an end-user by first removing the protective cap from the ring by disrupting the user-severable connections. The fluid transfer device 25 and/or sealing stoppers or membranes provided with the connector assembly can be activated in accordance with their function, and the dry drug held in the vial reconstituted and delivered. After the drug has been delivered, the ring may be displaced proximally relative to the collar to free the deflectable latches from engagement with the interior surface of the annulus section. A force may thereafter be applied to the collar to cause the 30 latches to deflect distally about the side section of the rim to remove the collar from the vial. The vial and connector assembly may thus be disposed of separately in accordance with applicable governmental regulations or industry practices.
BRlEF DESCRlPTlON OF TI~E D~AWINGS
Fig. 1 is an exploded view of one embodiment of a vial connector assembly in accordance with the present invention.
Fig. 2 is a cross-sectional view of the collar taken along line 2-2 of Fig. 1.
Fig 3 is another cross-sectional view of the collar, taken along line 3-3 of Fig. 1.
Fig. 4 is a cross-sectional view of the cap, taken along line 44 in Fig. I .
Fig. 5 is a perspective view illustrating the cap engaged with collar, for instance, when the vial and connector assembly are shipped to a pharmaceutical manufacturer for I ~ processing.
Fig. 6 is a partial cross-sectional view of the cap engaged with the collar taken along line 6-6 of Fig. ~.
Fig. 7 is a perspective view illustrating the cap engaged with the collar, for instance, after a drug has been processd by a pharrnaceutical manufacturer Fig. 8 is a partial cross-sectional view of the cap engaged with the collar taken along line 8-8 of Fig. 7.
Fig. 9 is a cross-sectional view of the cap engaged with the collar as taken along line 9-9 of Fig. 7.
Fig. 10 is an exploded view illustrating a user separating the user-severable connections between the cap and the ring in preparation of using the device.
Fig. 11 illustrates, in perspective view, activation of the fluid transfer device associated with the vial connector in preparation of a reconstituting a dry drug held within the vial.
Fig. 12 illustrates, in cross-section, a reconstitution operation.
2s Fig. 13 illustrates, in cross-section, moving the annulus ring in a proximal direction away from engagement with the collar in preparation of removing the vial connector from the vial.
Fig. 14 is an exploded view illustrating removing the vial connector from the vial.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIl~/fENTS
A connector assembly in accordance with the subject invention is identified generally by the numeral 10 in Fig. 1. The connector assembly 10 is used with a vial 12 having a bottom wall 14, a cylindrical side wall 16 extending upwardly from bottom wall 14, a shoulder 18 extending inwardly and upwardly from the end of cylindrical side wall 16 remote from bottom wall 14, and a cylindrical neck 20 of inside diameter "a" extending upwardly from shoulder 18 Neck 20 terminates at an open top 22 Top 22 is characterized by an annular rim 24 projecting outwardly thereabout. Annular rim 24 is characterized by a side portion 24a and an underside portion 24b Vial 12 is provided with a Iyophilized drug 26 stored therein. Connector assembly 10 functions to safely seal Iyophilized drug 26 in vial 12 and to permit a solvent to be added to vial 12 for mixing with Iyophilized drug 26 and forming a drug solution.
o Connector assembly 10 further enables delivery of the drug solution to an IV set for administration to a patient.
For purposes of illustration but not of limitation, connector assembly 10 in accordance with the subject invention is illustrated with various ancillary components not limiting the scope of applicability of the invention described and claimed herein. For example, connector assembly 10 as described herein is shown with a fluid transfer device 100 configured as a conventional spike. It will be evident to the skilled artisan that other fluid transfer devices, such as luer fittings, pointed needle cannulae, or the like may be employed with the connector assembly 10 of the present invention described herein. Fluid transfer device 100 may include structure 106 serving to retain various vial sealing 20 components. Here, there is illustrated a stopper 102 which serves to seal vial neck 20.
Also illustrated is a secondary seal 104 that may be disposed about fluid transfer device 100. It will be explicitly understood by the skilled artisan that other vial sealing devices may be used. Furthermore, there is shown a retractable shield 108 enabling the fluid access device to be shielded so as to prevent inadvertent touch contact with fluid transfer 2s device 100. It will be explicitly understood by the skilled artisan that other shielding devices may be employed with the connector assembly 10 as herein described. For instance, the shielding devices described in United States Patent No. 5,358,501 may be used with equal effect with the connector assembly described and claimed herein.Turning now to explanation of connector assembly 10, there is provided a 30 generally annular collar 30. As shown most clearly in Figs. 1-3, collar 30 has opposed proximal and distal ends 32 and 34, respectively. Proximal end 32 of collar 30 is defined by a plurality of deflectable latches 36 dimensioned to retain collar 30 in a locked position respective of annular rim 24, as well as to permit an end user to safely remove collar 30 from the rim when it is desired to dispose of the connector assembly separateiy from the vial Portions of collar 30 between proxima] and distal ends 32 and 34 define a sidewall33. Within sidewall 33 there may be provided radially inwardly extending annular ledge 38 having an inside diameter approximately equal to the inside diameter "a" of neck 20 of the vial 12. Ledge 38 may be provided for mounting fluid transfer components utilizable 5 with the connector assembly of the present invention.
Deflectable latches 36 each include a proximally facing, outwardly-canted surface 35 and a distally facing, inwardly canted locking surface 37. Outwardly-canted surface 35 facilitates proximal movement of collar 30 over rim 24 for movement of the connector assembly into locked position with the rim. Locking surface 37 is configured on each of lo . deflectable latches 36 for securely engaging underside portion 24b of the rim when collar 30 is locked to the rim. Deflectable latches 36 each feature an engagement surface 38 disposed on an exterior portion of the latches. Engagement surface 38 can be formed as an outside portion of latches 36 in a manner so as to be raised from the plane defined by sidewall 33 of the collar As seen in Figure 3, a diametrically opposed pair of engagement surfaces 38 define a diameter "X" As illustrated, latches 36 are preferably formed such that thcy cant slightly outwardly from a central axis "Z" running through collar 30 before the collar is locked to the rim. A proximal end of engagement surface 38 terminates before proximal end 32 of the collar to define a notch 40.
A removable safety cap 50 is provided for use with connector assembly 10 Removable safet,v cap 50 includes an open proximal end 52, a closed distal end 54, and a shield wall 56 formed therebetween. Cap 50 is configured to fit over the variouscomponents, such as the fluid transfer device or safety shield, provided for use with the connector assembly 10. Cap 50 may feature enlarged skirt portion 58 adjacent proximal end 52. Skirt portion 58 may feature one or more sealing ribs 60 which come into contact with sidewall 33 of collar 30 when cap 50 is placed thereover to enhance sterility maintenance of the various components, such as the fluid transfer device, located within shield wall 56. Sealing ribs 60 can be configured from various visco-elastic materials, such as rubber products, silicone products, or the like, to enhance the sterility-m~int~ining characteristics of cap 50. If sealing ribs 60 are formed from the same material forming cap 50, it will appreciated that various elastic materials can be applied to sidewall 33 to cooperate with the sealing ribs to enhance sealing performance between the sealing ribs and the sidewall of the collar.
A ring 61 is provided adjacent proximal end 52 of protective cap 50. Ring 61 includes an annulus section 62 having an interior surface 68. Interior surface 68 defines a diameter "Y" at least equal to, if not slightly less than, diameter "X" defined bet~een a diametrically opposed pair of engagement surfaces 38 Ring 61 is af~ixed to proximal end 52 of the cap by one or more user-severable connections 66 As principally disclosed herein, user-severable connections 66 can be formed as one or more frangible connections between the ring and the protective cap. The frangible connections can be formed as thinned sections of material linking the ring and the cap However, it will be evident to the skilled artisan that other user-severable connections, such as threaded connections, can also be employed A locking rib 7û is formed adjacent an open proximal end 64 associated with ring 61 A groove 71 disposed on interior surface 68 intermediate0 severable connections 66 and proximal end 64 can also be provided Operation of the connector assembly 10 in conjunction with its various stages shall now 17e descnbed, making reference to Figs. 5- 14.
Figs 5 and 6 are illustrative of vial connector assembly 10 as it might be shipped to a pharmaceutical manufacturer for processing and filling with a given drug 26 For instance, the device may be shipped such that collar 30 is disposed with respect to vial rim 24 in a removable manner. Locking surface 37 rests somewhat adjacent side portion 24a of the vial rim, without being placed into secure engagement with underside portion 24b of the vial rim. The various sealing components 102, 104 associated with fluid transfer device 100 can be engaged within vial neck 20 (not shown) Cap 50 is placed over collar 30 in a manner such that interior surface 68 of annulus 61 rests over a portion of side wall 33 located distally of eng~ging surface 38 It will be seen that deflectable latches 36 are canted in an outward manner away from central axis "Z" of collar 30. Sealing ribs 60 of the protective cap are disposed for engagement with sidewall 33 ofthe collar as previously described. The pharmaceutical m~mlf~turer can remove the cap and collar distally away from the vial rim in order to process and othen,vise fill a drug in vial 12.
After drug 26 has been filled and otherwise processed within the vial, the pharmaceutical manufacturer can secure vial connector 10 to the vial rim, as seen in Figs 7-9. Collar 30 and cap 50 are first returned to the positions illustrated in Figs. 5 and 6.
Thereafter, either by applying a proximally directed force onto protective cap 50, or by applying a distally~irected force onto vial 12, collar 30 and protective cap 50 are urged p~o~in,ally respective of rim 24. Aided by canted surfaces 35, collar 10 is urged proximally of vial rim 24b such that locking surfaces 37 are urged against underside portion 24b of the vial rim. Collar 30 is thus placed in locked position respective of rim 24, and further proximal movement of the collar is arrested Cap 50 continues to move CA 02211629 1997-07-28 ~
prox~mally respective of the collar. Ring 61~ together with protective cap 50, is urged proximally along sidewall 33 of the collar, with interior surface 68 of annulus 62 thrust into covering relationship with engaging surface 38 of the deflectable latches 36. Locking rib 70 is positioned into notch 40 located at the proximal edge of engaging surface 38.
s The dimensions of the cap and collar can be configured such that when locking rib 70 is engaged with notch 40, proximal end 34 of the collar rests against an inner shoulder 120 of the cap, preventing further proximal movement of the cap vis-à-vis the collar. Owing to the smaller diameter "Y" of annulus 62 vis-à-vis diameter "X" presented by diametrically opposed engaging surfaces 38, annulus 62 exerts an inwardly directed force 0 upon the latches. The effect is to lockingly secure the latches to the vial rim via the secure engagement between underside portion 24b of the via~ rim and engagement surface 37 of the deflectable latches. The various components can be configured such that when collar 30 and protective cap 50 are locked to the vial rim, the various sealing elements such as stopper 102 and secondary seal 104 (not shown) remain disposed in the vial neck in a J 5 ready-to activate state. Accordingly, vial 10 remains in a sterile, ready-to-use state In order to reconstitute dry drug 26 held in vial 12, the end-user must sever the user-severable connections 66 existing between proximal end 52 of the protective cap and ring 61. As illustrated in Fig. 10, a user, by applying digital pressure to ring 61, may either twist or axially pull cap 50 away from the ring in order to sever connections 66.
Protective cap 50 is simply lifted away from ring 61, exposing the fluid transfer device and associated components. Ring 61, by virtue of locking rib 70, remains in secure engagement with latches 36. It will be appreciated by the skilled artisan that any disruptions or breaks in user-severable connections 66 can be employed as tamper-evident means for the user, assuring integrity of drug 26 held therein.
Figs. 11 and 12 illustrate activation of fluid transfer device 100 and associated components in preparation of reconstituting drug 26 held within vial 12. For example, protective shield 108 can be thrust proximally, causing proximal motion of secondary seal 104 and stopper 102 towards the interior of vial 12 The effect is to open fluid path 150 between fluid transfer device 100 and the interior of vial 12, enabling fluid passage to and from a source of solvent "S". The skilled artisan will appreciate the mechanisms by which such fluid transfer devices can be employed with the vial connector of the present assembly, for instance, by making reference to U.S. Patent No. 5,358,501, whose disclosure is incorporated by reference herein.
. CA 02211629 1997-07-28 , . , P-,6,2 --I O--Assuming now that drug 26 held within the vial has been reconstituted and a desired quantity delivered to a patient~ a user will be desirous of disposing of the device, particularly vial 12 and vial connector assembly 10, in a safe and judicious manner. If desired, the end-user may disconnect vial connector assembly 10 from vial 12, enabling s both to be disposed of separately. Referring to Figs 13 and 14, in preparation of safe disposal, a user may wish to re-engage any safety implements provided, such as safety shield 108, so as to protect the user from inadvertent touch contact with fluid transfer device 100. For example, in the device disclosed by U S. Patent No 5,358,501, a needle guard is inherently part of the design. Securely gripping a portion of collar 30 with one lo hand, a user urges a proximally directed force onto ring 61. Ring 61 is caused to slide proximally away from latches 36, such that the ring will remain freely disposed about neck 20 of the vial. In the absence of an inwardly directed force between interior surface 68 of the annulus and engagement surface 38 of the latches, a user may simply exert a proximally-directed force upon collar 30 to remove same from vial neck 24. Deflectable latches 36, assisted by the inward canting of locking surfaces 37, will slide from engagement with underside portion 24b of the vial rim and around side portion 24a of the vial rim, permitting removal of collar 30. Vial connector assembly 10, inclusive of fluid transfer device 100 and the sealing components such as rubber stopper 102, are removed from vial 12. Fluid transfer device 100 is safely sheathed by any safety apparatus such as shield 108. Vial 12 may now be separately disposed of from vial connector 10 in any manner conforming to governmental regulations or industry practice standards.
The various components can be constructed from materials standard in the art.
For example, collar 30, cap 50, ring 61 or any of their sub-components can be injection-molded from conventional thermoplastics. Fluid access device 10 can be formed from 2s thermoplastics (e.g., if the fluid access device is formed as a spike or luer connector, for instance), or it can be provided as a cannula made from stainless steel ( if the cannula is sharp) or from a suitable thermoplastic (for instance, if the cannula is blunt). Various rubbers or elastomeric materials can be chosen for stoppers 102, 104. The vial can be formed from suitable glass or plastics materials adaptable to the particular drug held therein.
It will be appreciated and understood by those skilled in the art that further and additional forms of the invention may be devised without departing from the spirit and scope of the appended claims, the invention not being limited to the specific embodiments shown.
In the art, there are a number of ways to store dry drugs such as lyophilized drugs in a form conducive to reconstitution and delivery. Some of these products are exemplified, for example, by the MONOVIAL~-brand prefillable drug delivery devices m~nllf~ctllred and sold by Becton Dickinson Pharmaceutical Systems of Le Pont de Claix, France. Such systems are further exemplified, for instance, in U.S. Patent No. 5,358,501, issued to Gabriel Meyer on October 25, 1994. While there are variations of such systems, in general, they feature vials made of glass or suitable plastic materials, in which a selected dose of a Iyophilized drug may be stored. The vial is generally sealed to prevent deterioration or cont~min~tion of the drug. The dry drug may be reconstituted with a liquid solvent shortly prior to use, and the now reconstituted drug solution may be administered to a patient.
Various components are employed with the prefillable drug-delivery systems described above. For instance, the vials are typically provided with a vial connector assembly to enable attachment of the vial to a source of solvent to reconstitute the dry . CA 02211629 1997-07-28 _.
drug The same vial connector is also normally used to attach the vial to an intravenous fitting to deliver the reconstituted drug to a patient. Vial connectors such as used with the prefillable drug delivery systems described above typically include one or more components necessary for the function of the system For instance, one or more rubber s stopper or membrane components are provided to seal the vial until such time as access to the drug, in its dry or liquid form, is desired. A fluid transfer device, such as a needle or spike, is also provided, both to provide means for introducing solvent into the vial and for delivering the reconstituted drug out of the vial. Generally, a collar component is provided adjacent the rim of the vial to secure the various parts, such as the fluid transfer 0 device and the sealing components, associated with the vial connector.
Depending on the configuration of the prefillable drug-delivery system, the system might be activated by moving the collar relative to the vial rim, wherein the fluid transfer device and sealing components are fixed relative to the collar, or by moving the fluid transfer device and sealing components relative to the vial, wherein the collar is fixed 15 relative to the vial rim. movable manner relative to the collar. Accordingly, depending on the configuration, the system can be activated either by causing motion between the collar and the rim, or by causing motion between the fluid transfer device and/or sealing components relative to the collar.
One aspect of the aforementioned systems is that subsequent to use, the various 20 components, such as the fluid transfer device, sealing components, and the collar itself remain fixed to the vial. Here, once the drug has been delivered to the patient, the entire system is disposed of whole in a sterile manner. Owing to the di~el ellt materials used for the various components, benefits may be realized in configuring a system wherein the components can be separated from one another in a safe manner to facilitate disposal. For 25 instance, certain governmental regulations or accepted practices may encourage disposing of the vial, which contained the drug in its dry and reconstituted forms, separately from the transfer assembly.
- SUMMA~Y OF THE ~NVENTION
The subject invention is directed to a connector assembly for use with a vial. The vial includes a bottom wall and an upstanding side wall. A shoulder extends inwardly from the top end of the side wall and a tubular neck extends upwardly from the shoulder to an open top. An annular rim may extend around portions of the neck that define the .
~ P- ,632 , - open top. Portions of the vial between the tubular neck and the bottom wall define an enclosure in which a Iyophilized drug or a drug solution may be stored.
A novel aspect of the connector assembly in accordance with the present invention is that it is mountable to the neck of the vial in a manner such that it may be safely 5 removed by a practitioner, such that the connector assembly may be disposed of separately from the vial. The connector assembly can be employed with various fluid transfer devices, such as a needle, a spike or a luer. as means for introducing solvent into the vial and for delivering a reconstituted drug out of the vial. Various stoppers and membrane components may be provided in conjunction with the connector assembly to seal the vial lo until such time as access to the drug, in its dry or liquid form, is desired.The connector assembly includes a collar mountable to the rim of the vial neck.
The collar includes a proximal end, a distal end, and a sidewall therebetween. A plurality of deflectable latches are provided adjacent the proximal end of the collar. The plurality of deflectable latches each include locking means deflectable about a side portion of the rim 15 for secure engagement with the underside of the rim In one configuration, the locking means can be formed as a proximally facing, inwardly canted locking surface provided adjacent the proximal end of each of the deflectable latches.
The connector assembly includes a protective cap mountable about the sidewall portion of the collar which cooperates with the collar to secure the connector assembly to 20 the vial rim. The protective cap features an open plo~h-,al end, a closed distal end, and a shield wall formed therebetween. A ring is provided adjacent the open proximal end of the protective cap. The ring features an annulus-section with an interior surface cooperable with structure associated with the deflectable latches and is connected to the proximal end of the protective cap by one or more user-severable connections. In one 25 embodiment, the user-severable connections are formed as one or more frangible sections formed between the proximal end of the cap and a distal end end of the ring. The ring may include a rib element formed at a proximal end thereof. The rib element may cooperate with structure provided on the deflectable latches to prevent further distal movement of the ring after the collar is urged into a locked position with the vial rim. The 30 interior surface of the annular section may define a diameter equal to, or slightly less than, a diameter defined by a diametrically opposed pair of deflectable latches, such that the annulus section will apply an inwardly-directed holding force onto the deflectable latches.
The inwardly directed force will retain the collar in a locked position respective of the vial rlm.
, The device may be supplied to a pharmaceutical manu~acturer in a manner to enable processing and filling of the vial with a desired drug. After the drug is filled into the vial, the collar can be lockingly secured to the vial nm for shipment to an end user.
The collar, together with the fluid transfer device and the various sealing stoppers and/or membranes associated with the connector assembly, are positioned in a manner to seal the open top of the vial. The protective cap is then mounted about the sidewall portion of the collar If provided, sterility ribs provided on an interior portion of the cap cooperate with the sidewall of the collar to provide added sealing security for the drug retained within the vial as well as for the various components associated with the connector assembly.
o Continued proximal motion of the cap relative to the collar will cause the annulus section to engage the deflectable latches, such that cap and collar are both moved proximally relative to the rim. The action of the protective cap against the collar and, in particular, engagement forces exerted between the annulus section of the ring and the deflectable latches of the collar, causes the deflectable latches, and particularly the locking 15 means associated therewith, to move into secure engagement with an underside portion of the rim. The annulus section proceeds proximally relative to the collar, such that the interior surface of the annulus-section is disposed in covering relationship with the deflectable latches of the collar. The rib element provided at the proximal end of the ring retains the ring in fixed position relative to the deflectable latches in a manner such that the 20 ring cannot be further removed in a distal direction. Accordingly, inwardly directed forces are exerted by the annulus-section onto the deflectable latches, to hold the collar in locked position relative to the rim. The device may thus be shipped to an end-user.
The device may be activated by an end-user by first removing the protective cap from the ring by disrupting the user-severable connections. The fluid transfer device 25 and/or sealing stoppers or membranes provided with the connector assembly can be activated in accordance with their function, and the dry drug held in the vial reconstituted and delivered. After the drug has been delivered, the ring may be displaced proximally relative to the collar to free the deflectable latches from engagement with the interior surface of the annulus section. A force may thereafter be applied to the collar to cause the 30 latches to deflect distally about the side section of the rim to remove the collar from the vial. The vial and connector assembly may thus be disposed of separately in accordance with applicable governmental regulations or industry practices.
BRlEF DESCRlPTlON OF TI~E D~AWINGS
Fig. 1 is an exploded view of one embodiment of a vial connector assembly in accordance with the present invention.
Fig. 2 is a cross-sectional view of the collar taken along line 2-2 of Fig. 1.
Fig 3 is another cross-sectional view of the collar, taken along line 3-3 of Fig. 1.
Fig. 4 is a cross-sectional view of the cap, taken along line 44 in Fig. I .
Fig. 5 is a perspective view illustrating the cap engaged with collar, for instance, when the vial and connector assembly are shipped to a pharmaceutical manufacturer for I ~ processing.
Fig. 6 is a partial cross-sectional view of the cap engaged with the collar taken along line 6-6 of Fig. ~.
Fig. 7 is a perspective view illustrating the cap engaged with the collar, for instance, after a drug has been processd by a pharrnaceutical manufacturer Fig. 8 is a partial cross-sectional view of the cap engaged with the collar taken along line 8-8 of Fig. 7.
Fig. 9 is a cross-sectional view of the cap engaged with the collar as taken along line 9-9 of Fig. 7.
Fig. 10 is an exploded view illustrating a user separating the user-severable connections between the cap and the ring in preparation of using the device.
Fig. 11 illustrates, in perspective view, activation of the fluid transfer device associated with the vial connector in preparation of a reconstituting a dry drug held within the vial.
Fig. 12 illustrates, in cross-section, a reconstitution operation.
2s Fig. 13 illustrates, in cross-section, moving the annulus ring in a proximal direction away from engagement with the collar in preparation of removing the vial connector from the vial.
Fig. 14 is an exploded view illustrating removing the vial connector from the vial.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIl~/fENTS
A connector assembly in accordance with the subject invention is identified generally by the numeral 10 in Fig. 1. The connector assembly 10 is used with a vial 12 having a bottom wall 14, a cylindrical side wall 16 extending upwardly from bottom wall 14, a shoulder 18 extending inwardly and upwardly from the end of cylindrical side wall 16 remote from bottom wall 14, and a cylindrical neck 20 of inside diameter "a" extending upwardly from shoulder 18 Neck 20 terminates at an open top 22 Top 22 is characterized by an annular rim 24 projecting outwardly thereabout. Annular rim 24 is characterized by a side portion 24a and an underside portion 24b Vial 12 is provided with a Iyophilized drug 26 stored therein. Connector assembly 10 functions to safely seal Iyophilized drug 26 in vial 12 and to permit a solvent to be added to vial 12 for mixing with Iyophilized drug 26 and forming a drug solution.
o Connector assembly 10 further enables delivery of the drug solution to an IV set for administration to a patient.
For purposes of illustration but not of limitation, connector assembly 10 in accordance with the subject invention is illustrated with various ancillary components not limiting the scope of applicability of the invention described and claimed herein. For example, connector assembly 10 as described herein is shown with a fluid transfer device 100 configured as a conventional spike. It will be evident to the skilled artisan that other fluid transfer devices, such as luer fittings, pointed needle cannulae, or the like may be employed with the connector assembly 10 of the present invention described herein. Fluid transfer device 100 may include structure 106 serving to retain various vial sealing 20 components. Here, there is illustrated a stopper 102 which serves to seal vial neck 20.
Also illustrated is a secondary seal 104 that may be disposed about fluid transfer device 100. It will be explicitly understood by the skilled artisan that other vial sealing devices may be used. Furthermore, there is shown a retractable shield 108 enabling the fluid access device to be shielded so as to prevent inadvertent touch contact with fluid transfer 2s device 100. It will be explicitly understood by the skilled artisan that other shielding devices may be employed with the connector assembly 10 as herein described. For instance, the shielding devices described in United States Patent No. 5,358,501 may be used with equal effect with the connector assembly described and claimed herein.Turning now to explanation of connector assembly 10, there is provided a 30 generally annular collar 30. As shown most clearly in Figs. 1-3, collar 30 has opposed proximal and distal ends 32 and 34, respectively. Proximal end 32 of collar 30 is defined by a plurality of deflectable latches 36 dimensioned to retain collar 30 in a locked position respective of annular rim 24, as well as to permit an end user to safely remove collar 30 from the rim when it is desired to dispose of the connector assembly separateiy from the vial Portions of collar 30 between proxima] and distal ends 32 and 34 define a sidewall33. Within sidewall 33 there may be provided radially inwardly extending annular ledge 38 having an inside diameter approximately equal to the inside diameter "a" of neck 20 of the vial 12. Ledge 38 may be provided for mounting fluid transfer components utilizable 5 with the connector assembly of the present invention.
Deflectable latches 36 each include a proximally facing, outwardly-canted surface 35 and a distally facing, inwardly canted locking surface 37. Outwardly-canted surface 35 facilitates proximal movement of collar 30 over rim 24 for movement of the connector assembly into locked position with the rim. Locking surface 37 is configured on each of lo . deflectable latches 36 for securely engaging underside portion 24b of the rim when collar 30 is locked to the rim. Deflectable latches 36 each feature an engagement surface 38 disposed on an exterior portion of the latches. Engagement surface 38 can be formed as an outside portion of latches 36 in a manner so as to be raised from the plane defined by sidewall 33 of the collar As seen in Figure 3, a diametrically opposed pair of engagement surfaces 38 define a diameter "X" As illustrated, latches 36 are preferably formed such that thcy cant slightly outwardly from a central axis "Z" running through collar 30 before the collar is locked to the rim. A proximal end of engagement surface 38 terminates before proximal end 32 of the collar to define a notch 40.
A removable safety cap 50 is provided for use with connector assembly 10 Removable safet,v cap 50 includes an open proximal end 52, a closed distal end 54, and a shield wall 56 formed therebetween. Cap 50 is configured to fit over the variouscomponents, such as the fluid transfer device or safety shield, provided for use with the connector assembly 10. Cap 50 may feature enlarged skirt portion 58 adjacent proximal end 52. Skirt portion 58 may feature one or more sealing ribs 60 which come into contact with sidewall 33 of collar 30 when cap 50 is placed thereover to enhance sterility maintenance of the various components, such as the fluid transfer device, located within shield wall 56. Sealing ribs 60 can be configured from various visco-elastic materials, such as rubber products, silicone products, or the like, to enhance the sterility-m~int~ining characteristics of cap 50. If sealing ribs 60 are formed from the same material forming cap 50, it will appreciated that various elastic materials can be applied to sidewall 33 to cooperate with the sealing ribs to enhance sealing performance between the sealing ribs and the sidewall of the collar.
A ring 61 is provided adjacent proximal end 52 of protective cap 50. Ring 61 includes an annulus section 62 having an interior surface 68. Interior surface 68 defines a diameter "Y" at least equal to, if not slightly less than, diameter "X" defined bet~een a diametrically opposed pair of engagement surfaces 38 Ring 61 is af~ixed to proximal end 52 of the cap by one or more user-severable connections 66 As principally disclosed herein, user-severable connections 66 can be formed as one or more frangible connections between the ring and the protective cap. The frangible connections can be formed as thinned sections of material linking the ring and the cap However, it will be evident to the skilled artisan that other user-severable connections, such as threaded connections, can also be employed A locking rib 7û is formed adjacent an open proximal end 64 associated with ring 61 A groove 71 disposed on interior surface 68 intermediate0 severable connections 66 and proximal end 64 can also be provided Operation of the connector assembly 10 in conjunction with its various stages shall now 17e descnbed, making reference to Figs. 5- 14.
Figs 5 and 6 are illustrative of vial connector assembly 10 as it might be shipped to a pharmaceutical manufacturer for processing and filling with a given drug 26 For instance, the device may be shipped such that collar 30 is disposed with respect to vial rim 24 in a removable manner. Locking surface 37 rests somewhat adjacent side portion 24a of the vial rim, without being placed into secure engagement with underside portion 24b of the vial rim. The various sealing components 102, 104 associated with fluid transfer device 100 can be engaged within vial neck 20 (not shown) Cap 50 is placed over collar 30 in a manner such that interior surface 68 of annulus 61 rests over a portion of side wall 33 located distally of eng~ging surface 38 It will be seen that deflectable latches 36 are canted in an outward manner away from central axis "Z" of collar 30. Sealing ribs 60 of the protective cap are disposed for engagement with sidewall 33 ofthe collar as previously described. The pharmaceutical m~mlf~turer can remove the cap and collar distally away from the vial rim in order to process and othen,vise fill a drug in vial 12.
After drug 26 has been filled and otherwise processed within the vial, the pharmaceutical manufacturer can secure vial connector 10 to the vial rim, as seen in Figs 7-9. Collar 30 and cap 50 are first returned to the positions illustrated in Figs. 5 and 6.
Thereafter, either by applying a proximally directed force onto protective cap 50, or by applying a distally~irected force onto vial 12, collar 30 and protective cap 50 are urged p~o~in,ally respective of rim 24. Aided by canted surfaces 35, collar 10 is urged proximally of vial rim 24b such that locking surfaces 37 are urged against underside portion 24b of the vial rim. Collar 30 is thus placed in locked position respective of rim 24, and further proximal movement of the collar is arrested Cap 50 continues to move CA 02211629 1997-07-28 ~
prox~mally respective of the collar. Ring 61~ together with protective cap 50, is urged proximally along sidewall 33 of the collar, with interior surface 68 of annulus 62 thrust into covering relationship with engaging surface 38 of the deflectable latches 36. Locking rib 70 is positioned into notch 40 located at the proximal edge of engaging surface 38.
s The dimensions of the cap and collar can be configured such that when locking rib 70 is engaged with notch 40, proximal end 34 of the collar rests against an inner shoulder 120 of the cap, preventing further proximal movement of the cap vis-à-vis the collar. Owing to the smaller diameter "Y" of annulus 62 vis-à-vis diameter "X" presented by diametrically opposed engaging surfaces 38, annulus 62 exerts an inwardly directed force 0 upon the latches. The effect is to lockingly secure the latches to the vial rim via the secure engagement between underside portion 24b of the via~ rim and engagement surface 37 of the deflectable latches. The various components can be configured such that when collar 30 and protective cap 50 are locked to the vial rim, the various sealing elements such as stopper 102 and secondary seal 104 (not shown) remain disposed in the vial neck in a J 5 ready-to activate state. Accordingly, vial 10 remains in a sterile, ready-to-use state In order to reconstitute dry drug 26 held in vial 12, the end-user must sever the user-severable connections 66 existing between proximal end 52 of the protective cap and ring 61. As illustrated in Fig. 10, a user, by applying digital pressure to ring 61, may either twist or axially pull cap 50 away from the ring in order to sever connections 66.
Protective cap 50 is simply lifted away from ring 61, exposing the fluid transfer device and associated components. Ring 61, by virtue of locking rib 70, remains in secure engagement with latches 36. It will be appreciated by the skilled artisan that any disruptions or breaks in user-severable connections 66 can be employed as tamper-evident means for the user, assuring integrity of drug 26 held therein.
Figs. 11 and 12 illustrate activation of fluid transfer device 100 and associated components in preparation of reconstituting drug 26 held within vial 12. For example, protective shield 108 can be thrust proximally, causing proximal motion of secondary seal 104 and stopper 102 towards the interior of vial 12 The effect is to open fluid path 150 between fluid transfer device 100 and the interior of vial 12, enabling fluid passage to and from a source of solvent "S". The skilled artisan will appreciate the mechanisms by which such fluid transfer devices can be employed with the vial connector of the present assembly, for instance, by making reference to U.S. Patent No. 5,358,501, whose disclosure is incorporated by reference herein.
. CA 02211629 1997-07-28 , . , P-,6,2 --I O--Assuming now that drug 26 held within the vial has been reconstituted and a desired quantity delivered to a patient~ a user will be desirous of disposing of the device, particularly vial 12 and vial connector assembly 10, in a safe and judicious manner. If desired, the end-user may disconnect vial connector assembly 10 from vial 12, enabling s both to be disposed of separately. Referring to Figs 13 and 14, in preparation of safe disposal, a user may wish to re-engage any safety implements provided, such as safety shield 108, so as to protect the user from inadvertent touch contact with fluid transfer device 100. For example, in the device disclosed by U S. Patent No 5,358,501, a needle guard is inherently part of the design. Securely gripping a portion of collar 30 with one lo hand, a user urges a proximally directed force onto ring 61. Ring 61 is caused to slide proximally away from latches 36, such that the ring will remain freely disposed about neck 20 of the vial. In the absence of an inwardly directed force between interior surface 68 of the annulus and engagement surface 38 of the latches, a user may simply exert a proximally-directed force upon collar 30 to remove same from vial neck 24. Deflectable latches 36, assisted by the inward canting of locking surfaces 37, will slide from engagement with underside portion 24b of the vial rim and around side portion 24a of the vial rim, permitting removal of collar 30. Vial connector assembly 10, inclusive of fluid transfer device 100 and the sealing components such as rubber stopper 102, are removed from vial 12. Fluid transfer device 100 is safely sheathed by any safety apparatus such as shield 108. Vial 12 may now be separately disposed of from vial connector 10 in any manner conforming to governmental regulations or industry practice standards.
The various components can be constructed from materials standard in the art.
For example, collar 30, cap 50, ring 61 or any of their sub-components can be injection-molded from conventional thermoplastics. Fluid access device 10 can be formed from 2s thermoplastics (e.g., if the fluid access device is formed as a spike or luer connector, for instance), or it can be provided as a cannula made from stainless steel ( if the cannula is sharp) or from a suitable thermoplastic (for instance, if the cannula is blunt). Various rubbers or elastomeric materials can be chosen for stoppers 102, 104. The vial can be formed from suitable glass or plastics materials adaptable to the particular drug held therein.
It will be appreciated and understood by those skilled in the art that further and additional forms of the invention may be devised without departing from the spirit and scope of the appended claims, the invention not being limited to the specific embodiments shown.
Claims (15)
1. A connector assembly mountable to the neck of a vial, the neck provided with a rim at an open proximal end of the vial, the rim having a side portion and an underside facing away from the open proximal end of the vial, comprising:
a collar mountable to the rim of the vial neck between a first position, wherein the collar is removably secured to the rim of the vial neck, and a second position, wherein the collar is fixedly secured to the rim of the vial neck, said collar including a proximal end, a distal end, and a sidewall therebetween, a plurality of deflectable latches provided adjacent the proximal end of the collar, each of said latches including locking means deflectable about the side portion of the rim for secured engagement with the underside of the rim when the collar is in said second position;
a protective cap mountable about the sidewall portion of the collar, the protective cap having an open proximal end, a closed distal end, and a shield wall formed therebetween, a ring provided adjacent the open proximal end of the cap and connected thereto by a user-severable connection, said ring having an annulus section with an interior surface cooperable with the locking means of the latches to secure said collar in said second position, the cap having a removable position, wherein the collar is in said first position and said cap is mountable to the collar such that the annulus section is located distally of said locking means, and an engagement position, wherein the cap is urged in a proximal direction such that the interior surface of said annulus section is positioned in cooperating relation with the locking means of said latches to secure the collar in said second position.
a collar mountable to the rim of the vial neck between a first position, wherein the collar is removably secured to the rim of the vial neck, and a second position, wherein the collar is fixedly secured to the rim of the vial neck, said collar including a proximal end, a distal end, and a sidewall therebetween, a plurality of deflectable latches provided adjacent the proximal end of the collar, each of said latches including locking means deflectable about the side portion of the rim for secured engagement with the underside of the rim when the collar is in said second position;
a protective cap mountable about the sidewall portion of the collar, the protective cap having an open proximal end, a closed distal end, and a shield wall formed therebetween, a ring provided adjacent the open proximal end of the cap and connected thereto by a user-severable connection, said ring having an annulus section with an interior surface cooperable with the locking means of the latches to secure said collar in said second position, the cap having a removable position, wherein the collar is in said first position and said cap is mountable to the collar such that the annulus section is located distally of said locking means, and an engagement position, wherein the cap is urged in a proximal direction such that the interior surface of said annulus section is positioned in cooperating relation with the locking means of said latches to secure the collar in said second position.
2. The connector assembly of Claim 1, wherein said protective cap is removable from said engagement position by releasing the user-severable connection between said ring and said protective cap.
3. The connector assembly of Claim 1, wherein said severable connection comprises one or more frangible sections located between the proximal end of said protective cap and said ring.
4. The connector assembly of Claim 1, wherein said user-severable connection comprises a threaded connection between the proximal end of said protective cap and said ring
5. The connector assembly of Claim 1, wherein said locking means comprises:
a locking element located at a proximal end of the locking means; and an engagement surface secured in functional relation with said locking element and cooperable with the interior surface of said annulus section, wherein when said ring is urged in the proximal direction, the interior surface of said annulus section will be thrust into covering relation with the engagement surface to transmit an inwardly-directed force to said locking element to retain same in secured relation with the underside of said rim.
a locking element located at a proximal end of the locking means; and an engagement surface secured in functional relation with said locking element and cooperable with the interior surface of said annulus section, wherein when said ring is urged in the proximal direction, the interior surface of said annulus section will be thrust into covering relation with the engagement surface to transmit an inwardly-directed force to said locking element to retain same in secured relation with the underside of said rim.
6. The connector assembly of Claim 5, wherein the interior surface of said annulus section includes a rib element adjacent the proximal end of the ring, wherein said rib element is cooperable with said engagement surface when the ring is urged in the proximal direction to prevent removal of said ring in a distal direction.
7. The connector assembly of Claim 6, wherein said annulus section is removable from said engagement surface in a proximal direction, wherein in the absence of said inwardly-directed force upon said locking element, said locking elements are deflectable about the side portion of the rim to remove the collar from the vial.
8. A connector assembly mountable to the neck of a vial, the neck provided with a rim at an open proximal end of the vial, the rim having a side portion and an underside facing away from the open proximal end of the vial, comprising:
a collar mountable to the rim of the vial neck between a first position, wherein the collar is removably secured to the rim of the vial neck, and a second position, wherein the collar is fixedly secured to the rim of the vial neck, said collar including a proximal end, a distal end, and a sidewall therebetween, a plurality of deflectable latches provided adjacent the proximal end of the collar, each of said latches including locking means comprising a locking hook deflectable about the side portion of the rim for secured engagement with the underside of the rim when the collar is in said second position and an engagement surface disposed in functional relation with said locking hook, wherein a pair of opposed engagement surfaces defines a first diameter;
a protective cap mountable about the sidewall portion of the collar, the protective cap having an open proximal end, a closed distal end, and a shield wall formed therebetween, a ring provided adjacent the open proximal end of the cap and connected thereto by one or more user-severable connections, said ring having an annulus section defining an interior surface with a second diameter equal to or less than the first diameter of the pair of opposed engagement surfaces, said interior surface cooperable with the locking means of the latches to secure said collar in said second position, the cap having a removable position, wherein the collar is in said first position and said cap is mountable to the collar such that the annulus section is located distally of said locking means, and an engagement position, wherein the cap is urged in a proximal direction such that the interior surface of said annulus section is positioned in cooperating relation with the engagement surface of locking means of said latches to exert a force onto the locking hooks, urging said locking hooks into secured engagement with the underside of the rim to secure the collar in said second position.
a collar mountable to the rim of the vial neck between a first position, wherein the collar is removably secured to the rim of the vial neck, and a second position, wherein the collar is fixedly secured to the rim of the vial neck, said collar including a proximal end, a distal end, and a sidewall therebetween, a plurality of deflectable latches provided adjacent the proximal end of the collar, each of said latches including locking means comprising a locking hook deflectable about the side portion of the rim for secured engagement with the underside of the rim when the collar is in said second position and an engagement surface disposed in functional relation with said locking hook, wherein a pair of opposed engagement surfaces defines a first diameter;
a protective cap mountable about the sidewall portion of the collar, the protective cap having an open proximal end, a closed distal end, and a shield wall formed therebetween, a ring provided adjacent the open proximal end of the cap and connected thereto by one or more user-severable connections, said ring having an annulus section defining an interior surface with a second diameter equal to or less than the first diameter of the pair of opposed engagement surfaces, said interior surface cooperable with the locking means of the latches to secure said collar in said second position, the cap having a removable position, wherein the collar is in said first position and said cap is mountable to the collar such that the annulus section is located distally of said locking means, and an engagement position, wherein the cap is urged in a proximal direction such that the interior surface of said annulus section is positioned in cooperating relation with the engagement surface of locking means of said latches to exert a force onto the locking hooks, urging said locking hooks into secured engagement with the underside of the rim to secure the collar in said second position.
9. The connector assembly of Claim 8, wherein the sidewall of the collar defines a first plane and wherein the engagement surface of said locking means defines a second plane not co-planar with the first plane of the sidewall.
10. The connector assembly of Claim 9, wherein said deflectable latches are canted from the first plane of said sidewall.
11. The connector assembly of Claim 8, wherein said annulus section defines a first diameter and a pair of opposed latches define a second diameter, wherein the first diameter is equal to or less than the second diameter
12. The connector assembly of Claim 8, wherein the interior surface of said annulus section includes a rib element adjacent the proximal end of the ring, wherein said rib element is cooperable with said engagement surface when the ring is urged in the proximal direction to prevent removal of said ring in a distal direction
13. The connector assembly of Claim 12, wherein said annulus section is removable from said engagement surface in a proximal direction, wherein in the absence of said inwardly-directed force upon said engagement surface, said locking hooks are deflectable about the side portion of the rim to remove the collar from the vial
14. The connector assembly of Claim 8, wherein said collar is formed of a thermoplastic material.
15. The connector assembly of Claim 8, wherein said protective cap is formed of a thermoplastic material.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71490796A | 1996-09-17 | 1996-09-17 | |
| US08/714,907 | 1996-09-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2211629A1 true CA2211629A1 (en) | 1998-03-17 |
Family
ID=24871939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2211629 Abandoned CA2211629A1 (en) | 1996-09-17 | 1997-07-28 | Vial connector assembly for a medicament container |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5890610A (en) |
| EP (1) | EP0829250B1 (en) |
| JP (1) | JP2954550B2 (en) |
| KR (1) | KR19980024656A (en) |
| BR (1) | BR9704350A (en) |
| CA (1) | CA2211629A1 (en) |
| DE (1) | DE69724537T2 (en) |
| ES (1) | ES2205105T3 (en) |
| TW (1) | TW381973B (en) |
Families Citing this family (97)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3777587B2 (en) * | 1999-04-09 | 2006-05-24 | ニプロ株式会社 | Liquid container |
| US6957745B2 (en) * | 1998-04-20 | 2005-10-25 | Becton, Dickinson And Company | Transfer set |
| FR2783808B1 (en) | 1998-09-24 | 2000-12-08 | Biodome | CONNECTION DEVICE BETWEEN A CONTAINER AND A CONTAINER AND READY-TO-USE ASSEMBLY COMPRISING SUCH A DEVICE |
| US6183465B1 (en) * | 1999-09-01 | 2001-02-06 | Sherwood Services, Ag | Adapter for a feeding system |
| FR2802183B1 (en) | 1999-12-10 | 2002-02-22 | Biodome | METHOD FOR MANUFACTURING A CONNECTION DEVICE BETWEEN A CONTAINER AND A CONTAINER, CORRESPONDING CONNECTION DEVICE AND READY-TO-USE ASSEMBLY COMPRISING SUCH A DEVICE |
| JP3788164B2 (en) | 2000-02-21 | 2006-06-21 | 東海ゴム工業株式会社 | Fluid filled mount |
| AU2001242805A1 (en) * | 2000-04-04 | 2001-10-15 | Otsuka Pharmaceutical Factory, Inc. | Liquid container and liquid container connecting body using the liquid container |
| US6343629B1 (en) | 2000-06-02 | 2002-02-05 | Carmel Pharma Ab | Coupling device for coupling a vial connector to a drug vial |
| EP1414572B1 (en) * | 2001-08-10 | 2009-10-07 | Gen-Probe Incorporated | Connector for use in combining the contents of a pair of containers |
| ES2262733T3 (en) | 2001-12-17 | 2006-12-01 | Bristol-Myers Squibb Company | TRANSFER DEVICE AND SYSTEM THAT INCLUDES A COVER ASSEMBLY, A CONTAINER AND THE TRANSFER DEVICE. |
| US7923431B2 (en) * | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| FR2836129B1 (en) | 2002-02-20 | 2004-04-02 | Biodome | CONNECTION DEVICE BETWEEN A CONTAINER AND A CONTAINER AND READY-TO-USE ASSEMBLY COMPRISING SUCH A DEVICE |
| US20060043051A1 (en) * | 2002-07-11 | 2006-03-02 | Bissett Andrew S | Fast fit bottle mount |
| EP1573295A2 (en) * | 2002-12-11 | 2005-09-14 | Ferrosan A/S | Gelatine-based materials as swabs |
| ATE475434T1 (en) * | 2004-01-30 | 2010-08-15 | Ferrosan As | HEMOSTATIC SPRAYS AND COMPOSITIONS |
| CN101001649B (en) * | 2004-07-09 | 2011-08-31 | 弗罗桑医疗设备公司 | Haemostatic composition comprising hyaluronic acid and its preparation method |
| EP1693115B1 (en) * | 2005-02-22 | 2008-01-09 | Ing. Erich Pfeiffer GmbH | Fluid dispenser and assembling method |
| EP1820485B1 (en) * | 2006-02-16 | 2009-11-11 | F.Hoffmann-La Roche Ag | System and apparatus for extracting drugs |
| US7547300B2 (en) | 2006-04-12 | 2009-06-16 | Icu Medical, Inc. | Vial adaptor for regulating pressure |
| ES2425579T3 (en) | 2006-05-25 | 2013-10-16 | Bayer Healthcare, Llc | Reconstitution device |
| US7883499B2 (en) | 2007-03-09 | 2011-02-08 | Icu Medical, Inc. | Vial adaptors and vials for regulating pressure |
| EP2158042B1 (en) * | 2007-06-28 | 2016-11-09 | MeadWestvaco Calmar, Inc. | Bottle and valve fitment for containers |
| EP2188004A4 (en) | 2007-08-21 | 2015-06-17 | Yukon Medical Llc | Vial access and injection system |
| WO2009032762A2 (en) * | 2007-08-28 | 2009-03-12 | Meadwestvaco Calmar, Inc. | Plastic valves and methods of using the same |
| EP2259803B2 (en) * | 2008-02-29 | 2019-03-13 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
| EP2271387B1 (en) * | 2008-04-01 | 2016-06-15 | Yukon Medical, LLC | Dual container fluid transfer device |
| WO2010022095A1 (en) | 2008-08-20 | 2010-02-25 | Icu Medical, Inc. | Anti-reflux vial adaptors |
| US8512309B2 (en) * | 2009-01-15 | 2013-08-20 | Teva Medical Ltd. | Vial adapter element |
| US8123736B2 (en) * | 2009-02-10 | 2012-02-28 | Kraushaar Timothy Y | Cap adapters for medicament vial and associated methods |
| US8162914B2 (en) * | 2009-02-10 | 2012-04-24 | Kraushaar Timothy Y | Cap adapters for medicament vial and associated methods |
| IL201323A0 (en) | 2009-10-01 | 2010-05-31 | Medimop Medical Projects Ltd | Fluid transfer device for assembling a vial with pre-attached female connector |
| IL202069A0 (en) | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Fluid transfer device with sealing arrangement |
| IL202070A0 (en) | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Inline liquid drug medical device |
| JPWO2011068190A1 (en) * | 2009-12-04 | 2013-04-18 | テルモ株式会社 | Vial adapter |
| JP5881242B2 (en) * | 2010-02-01 | 2016-03-09 | 積水メディカル株式会社 | Plug body and fluid collection device set |
| BR112012020829B1 (en) | 2010-02-24 | 2020-04-14 | Medimop Medical Projects Ltd | liquid drug transfer device for use with a medical bottle |
| CN102711712B (en) | 2010-02-24 | 2014-08-13 | 麦迪麦珀医疗工程有限公司 | Fluid transfer assembly with venting arrangement |
| USD655017S1 (en) | 2010-06-17 | 2012-02-28 | Yukon Medical, Llc | Shroud |
| US9687644B2 (en) * | 2010-09-02 | 2017-06-27 | Hollister Incorporated | Soft, flexible connector |
| IL209290A0 (en) | 2010-11-14 | 2011-01-31 | Medimop Medical Projects Ltd | Inline liquid drug medical device having rotary flow control member |
| IT1403142B1 (en) * | 2010-11-19 | 2013-10-04 | Borla Ind | MIXING DEVICE FOR MEDICAL FLUIDS AND ITS ASSEMBLY PROCEDURE. |
| FR2967655B1 (en) * | 2010-11-24 | 2014-03-14 | Biocorp Rech Et Dev | DEVICE FOR CLOSING A CONTAINER, CONTAINER EQUIPPED WITH SUCH A DEVICE AND METHOD FOR CLOSING A BATCH OF SUCH CONTAINERS |
| IL212420A0 (en) | 2011-04-17 | 2011-06-30 | Medimop Medical Projects Ltd | Liquid drug transfer assembly |
| ES2934668T3 (en) | 2011-08-18 | 2023-02-23 | Icu Medical Inc | Pressure Regulating Vial Adapters |
| USD681230S1 (en) | 2011-09-08 | 2013-04-30 | Yukon Medical, Llc | Shroud |
| IL215699A0 (en) | 2011-10-11 | 2011-12-29 | Medimop Medical Projects Ltd | Liquid drug reconstitution assemblage for use with iv bag and drug vial |
| WO2013106757A1 (en) | 2012-01-13 | 2013-07-18 | Icu Medical, Inc. | Pressure-regulating vial adaptors and methods |
| USD720451S1 (en) | 2012-02-13 | 2014-12-30 | Medimop Medical Projects Ltd. | Liquid drug transfer assembly |
| USD737436S1 (en) | 2012-02-13 | 2015-08-25 | Medimop Medical Projects Ltd. | Liquid drug reconstitution assembly |
| JP6241624B2 (en) | 2012-03-06 | 2017-12-06 | フェロサン メディカル デバイシーズ エイ／エス | Pressurized container containing hemostatic paste |
| AU2013204180B2 (en) | 2012-03-22 | 2016-07-21 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
| IL219065A0 (en) | 2012-04-05 | 2012-07-31 | Medimop Medical Projects Ltd | Fluid transfer device with manual operated cartridge release arrangement |
| EP2825216B1 (en) | 2012-06-12 | 2015-08-19 | Ferrosan Medical Devices A/S | Dry haemostatic composition |
| USD769444S1 (en) | 2012-06-28 | 2016-10-18 | Yukon Medical, Llc | Adapter device |
| IL221634A0 (en) | 2012-08-26 | 2012-12-31 | Medimop Medical Projects Ltd | Universal drug vial adapter |
| IL221635A0 (en) | 2012-08-26 | 2012-12-31 | Medimop Medical Projects Ltd | Drug vial mixing and transfer device for use with iv bag and drug vial |
| JP5868555B2 (en) | 2012-09-13 | 2016-02-24 | メディモップ・メディカル・プロジェクツ・リミテッド | Nested female vial adapter |
| USD734868S1 (en) | 2012-11-27 | 2015-07-21 | Medimop Medical Projects Ltd. | Drug vial adapter with downwardly depending stopper |
| US9089475B2 (en) | 2013-01-23 | 2015-07-28 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
| ES2739291T3 (en) | 2013-01-23 | 2020-01-30 | Icu Medical Inc | Pressure regulation vial adapters |
| IL225734A0 (en) | 2013-04-14 | 2013-09-30 | Medimop Medical Projects Ltd | Ready-to-use drug vial assemblages including drug vial and drug vial closure having fluid transfer member, and drug vial closure therefor |
| DK2983745T3 (en) | 2013-05-10 | 2018-10-22 | West Pharma Services Il Ltd | Medical devices comprising ampoule adapter with interconnected module for dry drug |
| WO2014202760A2 (en) | 2013-06-21 | 2014-12-24 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
| JP6617101B2 (en) | 2013-07-19 | 2019-12-04 | アイシーユー メディカル インコーポレイテッド | Pressure regulating fluid transfer system and method |
| CN205626622U (en) | 2013-08-07 | 2016-10-12 | 麦迪麦珀医疗工程有限公司 | Liquid transfer device that is used together with infusion container |
| USD767124S1 (en) | 2013-08-07 | 2016-09-20 | Medimop Medical Projects Ltd. | Liquid transfer device with integral vial adapter |
| USD765837S1 (en) | 2013-08-07 | 2016-09-06 | Medimop Medical Projects Ltd. | Liquid transfer device with integral vial adapter |
| EP3470094B1 (en) | 2013-12-11 | 2020-07-22 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
| EP3138551A4 (en) * | 2014-05-02 | 2018-04-25 | JMS Co., Ltd. | Drug container connector and male member cover |
| AU2015277135B2 (en) | 2014-06-20 | 2020-02-20 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
| USD757933S1 (en) | 2014-09-11 | 2016-05-31 | Medimop Medical Projects Ltd. | Dual vial adapter assemblage |
| JP6726852B2 (en) | 2014-10-13 | 2020-07-22 | フェッローサン メディカル ディバイス エー／エス | Dry composition for use in hemostasis and wound healing |
| AR098591A1 (en) * | 2014-12-02 | 2016-06-01 | Juan Rosson Eduardo | SECURITY CLOSURE OF SHORT TURN FOR RECIPIENTS AND BOTTLE FOR SUCH CLOSURE |
| AU2015371184B2 (en) | 2014-12-24 | 2020-06-25 | Ferrosan Medical Devices A/S | Syringe for retaining and mixing first and second substances |
| JP6358724B2 (en) | 2015-01-05 | 2018-07-18 | ウエスト・ファーマ．サービシーズ・イスラエル，リミテッド | Dual vial adapter assembly with easy removable pill adapter to ensure accurate use |
| CA2986981A1 (en) | 2015-07-03 | 2017-01-12 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
| CN113143759B (en) | 2015-07-16 | 2024-01-30 | 西部制药服务以色列有限公司 | Liquid drug transfer device for secure telescopic snap-fit on an injection vial |
| USD801522S1 (en) | 2015-11-09 | 2017-10-31 | Medimop Medical Projects Ltd. | Fluid transfer assembly |
| BR112018010435B1 (en) | 2015-11-25 | 2022-06-28 | West Pharma. Services IL, Ltd. | DOUBLE AMPOULE ADAPTER SET FOR USE WITH A SYRINGE WITHOUT NEEDLE WITH A MALE CONNECTOR, A DRUG AMPOULE AND A LIQUID AMPOULE |
| CA3012733C (en) | 2016-01-29 | 2023-09-12 | Icu Medical, Inc. | Pressure-regulating vial adaptors |
| IL245803A0 (en) | 2016-05-24 | 2016-08-31 | West Pharma Services Il Ltd | Dual vial adapter assemblages including vented drug vial adapter and vented liquid vial adapter |
| IL245800A0 (en) | 2016-05-24 | 2016-08-31 | West Pharma Services Il Ltd | Dual vial adapter assemblages including identical twin vial adapters |
| IL246073A0 (en) | 2016-06-06 | 2016-08-31 | West Pharma Services Il Ltd | Fluid transfer devices for use with drug pump cartridge having slidable driving plunger |
| IL247376A0 (en) | 2016-08-21 | 2016-12-29 | Medimop Medical Projects Ltd | Syringe assembly |
| AU2017335746A1 (en) | 2016-09-30 | 2019-04-11 | Icu Medical, Inc. | Pressure-regulating vial access devices and methods |
| USD832430S1 (en) | 2016-11-15 | 2018-10-30 | West Pharma. Services IL, Ltd. | Dual vial adapter assemblage |
| IL249408A0 (en) | 2016-12-06 | 2017-03-30 | Medimop Medical Projects Ltd | Liquid transfer device for use with infusion liquid container and pincers-like hand tool for use therewith for releasing intact drug vial therefrom |
| IL251458A0 (en) | 2017-03-29 | 2017-06-29 | Medimop Medical Projects Ltd | User actuated liquid drug transfer devices for use in ready-to-use (rtu) liquid drug transfer assemblages |
| IL254802A0 (en) | 2017-09-29 | 2017-12-31 | Medimop Medical Projects Ltd | Dual vial adapter assemblages with twin vented female vial adapters |
| EP4321182A2 (en) | 2018-05-09 | 2024-02-14 | Ferrosan Medical Devices A/S | Method for preparing a haemostatic composition |
| USD903864S1 (en) | 2018-06-20 | 2020-12-01 | West Pharma. Services IL, Ltd. | Medication mixing apparatus |
| JP1630477S (en) | 2018-07-06 | 2019-05-07 | ||
| USD923812S1 (en) | 2019-01-16 | 2021-06-29 | West Pharma. Services IL, Ltd. | Medication mixing apparatus |
| JP1648075S (en) | 2019-01-17 | 2019-12-16 | ||
| PT3917486T (en) | 2019-01-31 | 2023-05-08 | West Pharma Services Il Ltd | Liquid transfer device |
| EP4360670A2 (en) | 2019-04-30 | 2024-05-01 | West Pharma Services IL, Ltd | Liquid transfer device with dual lumen iv spike |
| USD956958S1 (en) | 2020-07-13 | 2022-07-05 | West Pharma. Services IL, Ltd. | Liquid transfer device |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3587897A (en) * | 1969-06-25 | 1971-06-28 | West Co | Container closure |
| US4624393A (en) * | 1981-07-02 | 1986-11-25 | Survival Technology, Inc. | Split hub assembly for a necked down cartridge tube |
| US4619651A (en) * | 1984-04-16 | 1986-10-28 | Kopfer Rudolph J | Anti-aerosoling drug reconstitution device |
| DK0453555T3 (en) | 1989-11-13 | 1994-01-31 | Becton Dickinson France | Vial for storage of a drug substance |
| US5269429A (en) * | 1990-05-15 | 1993-12-14 | Robert Finke Gmbh & Co. Kg | Closure cap for infusion or transfusion bottles |
| US5085332B1 (en) * | 1991-04-11 | 1994-04-05 | Gettig Technologies Inc | Closure assembly |
| US5314084A (en) * | 1992-08-21 | 1994-05-24 | The West Company, Incorporated | Two piece all plastic seal |
| DE4228090C2 (en) * | 1992-08-24 | 1995-01-05 | Pohl Gmbh & Co Kg | Bottle cap |
| US5348174A (en) * | 1993-01-14 | 1994-09-20 | Eyelematic Manufacturing Co., Inc. | Metal flexible finger ferrule for flanged container closure |
| KR0119874Y1 (en) * | 1993-03-02 | 1998-06-01 | 이용학 | Synthetic resin sealing cap for a fluid bottle |
| US5562219A (en) * | 1994-09-22 | 1996-10-08 | Valois, S.A. | Device for attaching a dispenser member to a receptacle |
| FR2738550B1 (en) * | 1995-09-11 | 1997-11-07 | Biodome | DEVICE FOR SEALING A CONTAINER ITSELF CLOSED, ASSEMBLY FOR PROVIDING A PRODUCT COMPRISING SUCH A CONTAINER AND SUCH A SEALING DEVICE |
-
1997
- 1997-07-28 CA CA 2211629 patent/CA2211629A1/en not_active Abandoned
- 1997-08-12 BR BR9704350A patent/BR9704350A/en not_active IP Right Cessation
- 1997-09-13 KR KR1019970047346A patent/KR19980024656A/en not_active Application Discontinuation
- 1997-09-15 EP EP19970115999 patent/EP0829250B1/en not_active Expired - Lifetime
- 1997-09-15 ES ES97115999T patent/ES2205105T3/en not_active Expired - Lifetime
- 1997-09-15 DE DE1997624537 patent/DE69724537T2/en not_active Expired - Lifetime
- 1997-09-17 JP JP25159797A patent/JP2954550B2/en not_active Expired - Fee Related
- 1997-10-16 TW TW86113486A patent/TW381973B/en active
- 1997-11-03 US US08/962,897 patent/US5890610A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2954550B2 (en) | 1999-09-27 |
| JPH1099410A (en) | 1998-04-21 |
| KR19980024656A (en) | 1998-07-06 |
| EP0829250A3 (en) | 1998-05-20 |
| ES2205105T3 (en) | 2004-05-01 |
| BR9704350A (en) | 2004-03-09 |
| MX9707014A (en) | 1998-08-30 |
| EP0829250A2 (en) | 1998-03-18 |
| TW381973B (en) | 2000-02-11 |
| DE69724537T2 (en) | 2004-07-08 |
| DE69724537D1 (en) | 2003-10-09 |
| EP0829250B1 (en) | 2003-09-03 |
| US5890610A (en) | 1999-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0829250B1 (en) | An improved vial connector assembly for a medicament container | |
| CA2012587C (en) | Syringe having tamper evidence features | |
| JP2954549B2 (en) | Resealable connector assembly for container | |
| US5827262A (en) | Syringe device for mixing two compounds | |
| AU714070B2 (en) | Novel device | |
| KR102424269B1 (en) | Transfer device for media, comprising a non-releasably lockable adapter | |
| JP4124492B2 (en) | Sliding reconfigurable device with seal | |
| EP2608758B1 (en) | Assembly to facilitate user reconstitution | |
| CA1261700A (en) | Drug delivery system | |
| JP4884584B2 (en) | Transfer set for bottles and medical containers | |
| US5647849A (en) | Self-contained safety syringe | |
| US6632198B2 (en) | Retracting needle syringe | |
| JP2820249B2 (en) | Vial with resealable membrane assembly | |
| EP0570939A1 (en) | Solvent container with a means for communicating with a drug vial | |
| JP2001513682A (en) | Container cap assembly with closed penetrator | |
| JP2001513683A (en) | Container closure with brittle seal and connector for fluid transfer device | |
| MXPA04009341A (en) | Sliding reconstitution device for a diluent container. | |
| HUT73300A (en) | Closure for medication container | |
| CZ284900B6 (en) | In advance filled syringe for storage and discharge of a liquid and sterile therapeutic substance | |
| EP0904763A2 (en) | A locking ring connector assembly for a vial | |
| US6213994B1 (en) | Method and apparatus for fixing a connector assembly onto a vial | |
| JPH10295780A (en) | Fluid transportation device accessing fluid from vial and ampul and method to transport fluid using the same device | |
| MXPA97007014A (en) | An improved bottle connector assembly for a medicame container | |
| MXPA97007012A (en) | A transfer assembly for a medicinal container that has a valve without spark |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |